Loss of NIS expression, primarily driven by activated MAPK and PI3K/Akt pathways, is a hallmark of dedifferentiation and a primary cause of RAI resistance in advanced thyroid cancers [6,10,64]. Here, SLC5A5 is linked to thyroid cancer.